Vilin Bio Med Board of Directors

Get the latest insights into the leadership at Vilin Bio Med. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Madhusudhan Yadamakanti Reddy Managing Director
Mr. Viswa Prasad Sadhanala Director
Ms. Prasanna Lakshmi Venna Whole Time Director
Mr. Sasikanth Paritala Independent Director
Mr. Veeraiah Chowdary Kolla Independent Director
Mr. Girish Muktevi Independent Director

Vilin Bio Med Share price

VILINBIO

25.55

1.15 (4.71%)
Last updated on 15 Oct, 2025 | 14:21 IST
BUYSELL
Today's High

25.55

Today's Low

24.40

52 Week Low

16.25

52 Week High

32.50

The current prices are delayed, login to your account for live prices

Vilin Bio Med FAQs

The board at Vilin Bio Med consists of experienced professionals, including Mr. Madhusudhan Yadamakanti Reddy , Mr. Viswa Prasad Sadhanala , and others, overseeing the company’s strategic and corporate governance.

Directors at Vilin Bio Med are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Madhusudhan Yadamakanti Reddy is the current chairman at Vilin Bio Med.

Executive directors at Vilin Bio Med are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Vilin Bio Med adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Vilin Bio Med, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.